American Oriental Bioengineering (广西博科药业) reported mixed results for its first quarter. Revenue increased 19% from the year-earlier quarter to $46.1 million, but net income fell 16% to $7.9 million. American Oriental commented that $1.7 million in interest expense for newly issued convertible bonds was the major difference: increased interest expense changed the comparison with 2008’s Q1 from flat to lower. More details...

Stock Symbol: (NYSE: AOB)